Entrada Therapeutics, Inc. (TRDA)
6.64
-0.06
(-0.90%)
USD |
NASDAQ |
May 27, 16:00
6.64
0.00 (0.00%)
After-Hours: 16:39
Entrada Therapeutics Cash from Investing (Quarterly) : 26.99M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -431.90M |
| Tyra Biosciences, Inc. | -120.24M |
| Biogen, Inc. | -209.50M |
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| XOMA Royalty Corp. | 6.552M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.70M |
| Cash from Financing (Quarterly) | 0.10M |
| Free Cash Flow | -131.64M |
| Free Cash Flow Per Share (Quarterly) | -0.9977 |
| Free Cash Flow to Equity (Quarterly) | -40.56M |
| Free Cash Flow to Firm (Quarterly) | -41.74M |
| Free Cash Flow Yield | -47.70% |